Diagnosis of multiple system atrophy
- PMID: 29111419
- PMCID: PMC5869112
- DOI: 10.1016/j.autneu.2017.10.007
Diagnosis of multiple system atrophy
Abstract
Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders, particularly in the early stages of the disease. An autonomic-only presentation can be indistinguishable from pure autonomic failure. Patients presenting with parkinsonism may be misdiagnosed as having Parkinson disease. Patients presenting with the cerebellar phenotype of MSA can mimic other adult-onset ataxias due to alcohol, chemotherapeutic agents, lead, lithium, and toluene, or vitamin E deficiency, as well as paraneoplastic, autoimmune, or genetic ataxias. A careful medical history and meticulous neurological examination remain the cornerstone for the accurate diagnosis of MSA. Ancillary investigations are helpful to support the diagnosis, rule out potential mimics, and define therapeutic strategies. This review summarizes diagnostic investigations useful in the differential diagnosis of patients with suspected MSA. Currently used techniques include structural and functional brain imaging, cardiac sympathetic imaging, cardiovascular autonomic testing, olfactory testing, sleep study, urological evaluation, and dysphagia and cognitive assessments. Despite advances in the diagnostic tools for MSA in recent years and the availability of consensus criteria for clinical diagnosis, the diagnostic accuracy of MSA remains sub-optimal. As other diagnostic tools emerge, including skin biopsy, retinal biomarkers, blood and cerebrospinal fluid biomarkers, and advanced genetic testing, a more accurate and earlier recognition of MSA should be possible, even in the prodromal stages. This has important implications as misdiagnosis can result in inappropriate treatment, patient and family distress, and erroneous eligibility for clinical trials of disease-modifying drugs.
Keywords: Autonomic testing; Biomarkers; Diagnosis; Multiple system atrophy; Neuroimaging; Orthostatic hypotension.
Copyright © 2017 Elsevier B.V. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.Neurol Sci. 2022 Jan;43(1):187-198. doi: 10.1007/s10072-021-05746-6. Epub 2021 Nov 24. Neurol Sci. 2022. PMID: 34817726 Free PMC article. Review.
-
Autonomic innervation in multiple system atrophy and pure autonomic failure.J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1327-35. doi: 10.1136/jnnp.2009.198135. Epub 2010 Jul 26. J Neurol Neurosurg Psychiatry. 2010. PMID: 20660924
-
Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):56-60. doi: 10.1136/jnnp.74.1.56. J Neurol Neurosurg Psychiatry. 2003. PMID: 12486267 Free PMC article.
-
Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.Rev Neurol (Paris). 2024 Jan-Feb;180(1-2):79-93. doi: 10.1016/j.neurol.2023.12.004. Epub 2024 Jan 11. Rev Neurol (Paris). 2024. PMID: 38216420 Review.
-
Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):453-9. doi: 10.1136/jnnp-2011-301068. Epub 2012 Jan 6. J Neurol Neurosurg Psychiatry. 2012. PMID: 22228725 Free PMC article.
Cited by
-
A challenging case presentation of multiple system atrophy cerebellar type: A rare case report from Somalia.Radiol Case Rep. 2024 Sep 23;19(12):6183-6186. doi: 10.1016/j.radcr.2024.08.145. eCollection 2024 Dec. Radiol Case Rep. 2024. PMID: 39376957 Free PMC article.
-
Infections in the Etiology of Parkinson's Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications.J Parkinsons Dis. 2024;14(7):1301-1329. doi: 10.3233/JPD-240195. J Parkinsons Dis. 2024. PMID: 39331109 Free PMC article. Review.
-
Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays.PLoS Pathog. 2024 Sep 20;20(9):e1012554. doi: 10.1371/journal.ppat.1012554. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39302978 Free PMC article.
-
Exploring potential circRNA biomarkers for cancers based on double-line heterogeneous graph representation learning.BMC Med Inform Decis Mak. 2024 Jun 6;24(1):159. doi: 10.1186/s12911-024-02564-6. BMC Med Inform Decis Mak. 2024. PMID: 38844961 Free PMC article.
-
The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy.CNS Neurosci Ther. 2024 Apr;30(4):e14678. doi: 10.1111/cns.14678. CNS Neurosci Ther. 2024. PMID: 38572788 Free PMC article. Review.
References
-
- Anderson T, Luxon L, Quinn N, Daniel S, David Marsden C, Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Movement disorders : official journal of the Movement Disorder Society. 2008;23:977–984. - PubMed
-
- Arbizu J, Luquin MR, Abella J, de la Fuente-Fernandez R, Fernandez-Torron R, Garcia-Solis D, Garrastachu P, Jimenez-Hoyuela JM, Llaneza M, Lomena F, Lorenzo-Bosquet C, Marti MJ, Martinez-Castrillo JC, Mir P, Mitjavila M, Ruiz-Martinez J, Vela L. Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use. Rev Esp Med Nucl Imagen Mol. 2014;33:215–226. - PubMed
-
- Asahina M, Low DA, Mathias CJ, Fujinuma Y, Katagiri A, Yamanaka Y, Shimada J, Poudel A, Kuwabara S. Skin temperature of the hand in multiple system atrophy and Parkinson’s disease. Parkinsonism & related disorders. 2013;19:560–562. - PubMed
-
- Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage. 2000;11:805–821. - PubMed
-
- Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson’s disease. Lancet neurology. 2005;4:423–431. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
